RTX reported 12% organic sales growth and raised its full-year outlook, while the stock was roughly flat, up 0.6% after earnings. The quarter included a sizable contribution to adjusted EPS from IEPA cost recovery, and management flagged continuing work to reduce GTF-related aircraft-on-ground levels.
RTX shares rallied 9.2% following better-than-expected bookings and a raised full-year outlook driven by strong demand across commercial aerospace and defense segments.
RTX delivered a robust Q1, with 10% organic sales growth and a 21% increase in adjusted EPS driven by strong defense awards and continued commercial aerospace recovery.